ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024
Emergence of
Abstract read
In one paragraph
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Genomic global epidemiology and evolution ofMicrobial genomics · 2026Article
- Wildlife as a reservoir of OXA-48-like carbapenemase-producing Enterobacterales.Microbiology spectrum · 2026Article
- Performance of carbapenemase screening algorithms for detection of OXA-244-producingJAC-antimicrobial resistance · 2026Article
- Rising Incidence of New Delhi Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacterales, 10 US Sites, 2018-2023.Open forum infectious diseases · 2026Article
- Antimicrobial resistance, conjugative plasmids and pathogenicity in wastewater and freshwater Escherichia spp. in Stockholm, Sweden.npj antimicrobials and resistance · 2026Article
- Molecular Epidemiology of NDM-ProducingMicroorganisms · 2026Article
- Community-associated quinolone-resistant and extended-spectrum beta-lactamase-producingmSystems · 2026Article
- Emergence of OXA-48-like Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2026Article
- Whole-genome sequencing and molecular analysis of carbapenem-resistantFrontiers in microbiology · 2026Article
- Whole-genome characterisation of high-risk ST131 and the emerging ST1193 UPEC lineages in Romanian patients with recurrent urinary tract infections.Frontiers in microbiology · 2026Article
- Estimating the Value of Aztreonam-Avibactam in Treating Metallo-beta-Lactamase-Producing Enterobacterales Infections in Spain Using the STEDI AMR Value Framework.Infectious diseases and therapy · 2025Article
- Trends in UropathogenicOpen forum infectious diseases · 2025Article
- Use of Artificial Intelligence Methods for Improved Diagnosis of Urinary Tract Infections and Urinary Stone Disease.Journal of clinical medicine · 2025Review
- Community Outbreak of OXA-48-Producing Escherichia coli Linked to Food Premises, New Zealand, 2018-2022.Emerging infectious diseases · 2025Review
- Rapidly spreadingJournal of clinical microbiology · 2025Review
- CTX-M-ProducingInfection and drug resistance · 2025Review
- Combating antimicrobial resistance in Africa: a strategic roadmap for surveillance, stewardship, and research.Frontiers in cellular and infection microbiology · 2025Review
- From structured surveys to outbreak investigations: advancing genomic surveillance of carbapenem-resistant Enterobacterales within the European Antimicrobial Resistance Genes Surveillance Network.Frontiers in public health · 2025Article
- 'Antimicrobial resistance is invisible. I am not.'Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors.
Anke KohlenbergEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Olov SvartströmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Petra ApfalterAustrian National Reference Centre for Antimicrobial Resistance, Ordensklinikum Linz Elisabethinen, Linz, Austria.
Rainer HartlAustrian National Reference Centre for Antimicrobial Resistance, Ordensklinikum Linz Elisabethinen, Linz, Austria.
Pierre BogaertsNational Reference Centre for Antimicrobic-Resistant Gram-Negative Bacilli, Laboratory of Microbiology, CHU UCL Namur, Yvoir, Belgium.
Te-Din HuangNational Reference Centre for Antimicrobic-Resistant Gram-Negative Bacilli, Laboratory of Microbiology, CHU UCL Namur, Yvoir, Belgium.
Katerina ChudejovaDepartment of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia.
Lucia MalisovaNational Reference Laboratory for Antibiotics, National Institute of Public Health, Prague, Czechia.
Jessica EisfeldGerman National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Mirco SandfortDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Anette M HammerumNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Louise RoerNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Kati RäisänenFinnish Institute for Health and Welfare, Helsinki, Finland.
Laurent DortetAssociated French National Reference Centre for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Le Kremlin-Bicêtre, France.
Rémy A BonninAssociated French National Reference Centre for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Le Kremlin-Bicêtre, France.
Ákos TóthNational Centre for Public Health and Pharmacy, Budapest, Hungary.
Kinga TóthNational Centre for Public Health and Pharmacy, Budapest, Hungary.
Christina ClarkeGalway Reference Laboratory Service, Galway University Hospital, Galway, Ireland.
Martin CormicanSchool of Medicine, University of Galway, Galway, Ireland.
Algirdas GriškevičiusNational Public Health Surveillance Laboratory, Vilnius, Lithuania.
Kirstin KhonyongwaService Bactériologie-Mycologie-Antibiorésistance-Hygiène Hospitalière, Département de Microbiologie, Laboratoire National de Santé, Dudelange, Luxembourg.
Marie MeoService Bactériologie-Mycologie-Antibiorésistance-Hygiène Hospitalière, Département de Microbiologie, Laboratoire National de Santé, Dudelange, Luxembourg.
Baiba Niedre-OtomereNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases", Laboratory Service, Riga East University Hospital, Riga, Latvia.
Reinis VangravsNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases", Laboratory Service, Riga East University Hospital, Riga, Latvia.
Antoni Pa HendrickxCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Daan W NotermansCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Ørjan SamuelsenNorwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
Manuela CaniçaNational Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, Department of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Vera ManageiroNational Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, Department of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Vilhelm MüllerPublic Health Agency of Sweden, Solna, Sweden.
Barbro MäkitaloPublic Health Agency of Sweden, Solna, Sweden.
Urška KramarNational Laboratory of Health, Environment and Food, Centre for Medical Microbiology, Maribor, Slovenia.
Mateja PirsInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Daniel PalmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Dominique L MonnetEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Erik AlmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Marius LinkeviciusEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Analysis of 594 isolates of
Indexed as
Bacterial Proteinsbeta-LactamasesEscherichia coliEscherichia coli InfectionsEuropean UnionAnti-Bacterial AgentsEscherichia coli ProteinsEuropeHumansMicrobial Sensitivity TestsMultilocus Sequence TypingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseEscherichia coli Proteinsantibioticsantimicrobial resistancecarbapenemaseCarbapenem-resistant Enterobacteralescross-border spreadEscherichia colisurveillancewhole genome sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.